https://www.zacks.com/stock/news/2226281/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2226281
Feb 14, 2024 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.
zc:-437115244590792203
0
https://www.zacks.com/stock/news/2223473/zimmer-biomet-zbh-q4-earnings-top-estimates-margins-grow?cid=CS-ZC-FT-analyst_blog|earnings_article-2223473
Feb 08, 2024 - Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER in the fourth quarter.
zc:-3911721195332552432
0
https://www.zacks.com/stock/news/2222702/cvs-health-cvs-q4-earnings-top-estimates-2024-eps-view-down?cid=CS-ZC-FT-analyst_blog|earnings_article-2222702
Feb 07, 2024 - Robust sales growth across all three operating segments contributes to CVS Health's (CVS) Q4 revenues.
zc:8738929504936214596
0
https://seekingalpha.com/article/4666216-stryker-corporation-syk-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Jan 30, 2024 - Stryker Corporation (NYSE:NYSE:SYK) Q4 2023 Earnings Conference Call January 30, 2024 4:30 PM ETCompany ParticipantsKevin Lobo – Chair and Chief Executive...
0
sa:-1449456212807705850
0
https://www.zacks.com/stock/news/2218369/stryker-syk-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2218369
Jan 30, 2024 - The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-1240280503332944078
0
https://www.zacks.com/stock/news/2210235/stryker-s-syk-new-tech-aims-to-improve-surgeon-s-efficiency?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210235
Jan 15, 2024 - Stryker's (SYK) Blueprint Mixed Reality Guidance system aims to benefit shoulder arthroplasty surgeons by improving efficiency and minimizing errors.
zc:1828657819187297345
0
https://www.zacks.com/stock/news/2205154/hae-or-syk-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2205154
Jan 03, 2024 - HAE vs. SYK: Which Stock Is the Better Value Option?
zc:6876790493257642195
0
https://www.zacks.com/stock/news/2204574/will-stryker-syk-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204574
Jan 02, 2024 - Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:-3867728814712697247
0
https://www.zacks.com/stock/news/2199509/hae-vs-syk-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2199509
Dec 18, 2023 - HAE vs. SYK: Which Stock Is the Better Value Option?
zc:-1545456846804348860
0
https://www.zacks.com/commentary/2192786/top-stock-reports-for-berkshire-hathaway-mastercard-servicenow?cid=CS-ZC-FT-research_daily-2192786
Dec 04, 2023 - Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Mastercard Incorporated (MA) and ServiceNow, Inc. (NOW).
zc:111829010272554492
0